Renee D. Gala, SVP, Chief Financial Officer at Theravance Biopharma, Inc. (TBPH), sold 85,786 shares at $26.71 ($2.3M) on 2018-08-15, disclosed to the SEC on 2018-08-16.
Seasonal sale ($2.3M) by SVP, Chief Financial Officer — this insider has traded TBPH in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.74 | 2,204 | $61K | 2.7% |
| 2 | $27.74 | 2,204 | $61K | 2.7% |
| 3 | $26.71 | 39,839 | $1.1M | 46.3% |
| 4 | $26.71 | 39,839 | $1.1M | 46.3% |
| 5 | $27.43 | 1,700 | $47K | 2.0% |
| Total | $26.78 avg | 85,786 |
| $2.3M |
| 100% |
| Filing → |
| JAZZ | SELL | 2022-12-22 | $422K | — | Filing → |
| TBPH | SELL | 2018-05-22 | $243K | — | Filing → |
| CORT | BUY | 2018-03-07 | $155K | — | Filing → |